Sector: Diversified Consumer Services
|Large Cap
Dr. Lal Pathlabs Share Price
Dr. Lal Pathlabs Ltd.
₹1,624.40
-5.70(-0.35%)
Invest in LALPATHLAB with up to 2.86x margin.
Trade with MTF25th May 2026 | 2:42 PM
NSE : LALPATHLAB
Open Free Demat Account
Dr. Lal Pathlabs Performance
Price Movement
₹1624.40
₹1588.00
₹1651.50
↘ Today's Low↗ Today's High
1 Year Performance
₹1624.40
₹1272.60
₹1770.00
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹1,651.50
Low₹1,588.00
Open at₹1,640.00
Prev Close₹1,630.10
Volumes1.74 L
Avg Price₹1,626.02
Lower Circuit₹1,304.10
Upper Circuit₹1,956.10
Historical Performance
3M High₹1,719.90
3M Low₹1,272.60
1 Yr High₹1,770.00
1 Yr Low₹1,272.60
3 Yr High₹1,826.98
3 Yr Low₹958.02
5 Yr High₹2,122.75
5 Yr Low₹881.02
Dr. Lal Pathlabs Fundamentals
Market Cap
Market Runner Up
27,972 Cr.
PE Ratio (TTM)
High in industry
55.40
Dividend Yield
Market Runner Up
0.80
Net Profit TTM
3.6% incr over last year
504.80
Net Profit Growth
3.6% incr over last year
504.80
PEG Ratio
High in industry
15.20
ROE
10% decr over last year
20.12
Operating Revenue TTM
2,762.90
Operating Revenue Growth
12.2% incr over last year
Book Value
High in industry
10.90
MFI
MFI strongly Overbought
88.88
RSI
RSI Overbought
70.39
EPS (TTM)
30.24
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
27.32
Operating Profit Qtr.
186.80
Net Profit Qtr.
131.30
Operating Revenue Qtr.
702.70
PB Ratio
10.90
Dr. Lal Pathlabs Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 675.20 | 632.10 | 699.60 | 640.70 | 577.20 |
| Operating Expense | 493.70 | 458.40 | 484.50 | 457.30 | 418.10 |
| Operating Profit | 181.50 | 173.70 | 215.10 | 183.40 | 159.10 |
| Depreciation | 42.70 | 40.10 | 38.50 | 32.80 | 34.60 |
| Interest | 5.90 | 7 | 4.60 | 4.50 | 4.80 |
| Tax | 28.80 | 31 | 49.10 | 43.10 | -3.50 |
| Net Profit | 141.10 | 92.10 | 145.70 | 129.30 | 148.40 |
LALPATHLAB Stock Recommendation by HDFC
Research Type
Equity , Long Term
Buy Range
₹1,568 - ₹0
Target Price
₹1,740
Stop Loss
-
Target Date
6 Nov 26
Potential Returns
10.97 %
Dr. Lal Pathlabs Technicals
Dr. Lal Pathlabs Ltd. EMA & SMA
₹1624.40
-79.30 (-4.65%)
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Day EMA5 ₹1643
Day EMA10 ₹1606.9
Day EMA12 ₹1593.9
Day EMA20 ₹1550.6
Day EMA26 ₹1526.6
Day EMA50 ₹1476.2
Day EMA100 ₹1457.4
Day EMA200 ₹1461.6
Dr. Lal Pathlabs Support and Resistance
Resistance
First Resistance₹1733.07
Second Resistance₹1762.43
Third Resistance₹1804.97
Support
First Support₹1661.17
Second Support₹1618.63
Third Support₹1589.27
Technical Indicators
Day RSI70.39
Day MFI88.88
Day ADX39.67
Day Commodity Channel Index122.20
William-4.54
Day MACD67.30
Day MACD Signal Line55.63
Day ATR63.02
Day ROC1258.39
Day ROC2121.51
Dr. Lal Pathlabs Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 53.9 | 53.9 | 53.8 | 53.2 | 53.2 | 53.2 |
| FII | 26.8 | 23.9 | 21.7 | 21.9 | 20.3 | 17.2 |
| DII | 13.2 | 16.1 | 17.9 | 18.5 | 19.2 | 21.4 |
| Public | 5.8 | 5.8 | 6.2 | 6.1 | 6.9 | 7.9 |
Dr. Lal Pathlabs Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.06 L | 5.94 L | 51.58% |
| Week | 2.78 L | 4.96 L | 56.10% |
| 1 Month | 3.86 L | 9.39 L | 41.09% |
| 6 Month | 2.17 L | 4.01 L | 54.07% |
Dr. Lal Pathlabs SWOT Analysis
Strengths20
Weakness6
Opportunity2
Threats1
Companies with no Debt
Benjamin Graham Value Screen
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Negative to Positive growth in Sales and Profit with Strong Price momentum
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Dr. Lal Pathlabs Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jun, 2026 | 4 | FINAL | 26 Jun, 2026 | Equity Share |
| 05 Feb, 2026 | 3.5 | INTERIM | 05 Feb, 2026 | Equity Share |
| 07 Nov, 2025 | 7 | INTERIM | 07 Nov, 2025 | Equity Share |
| 06 Aug, 2025 | 6 | INTERIM | 06 Aug, 2025 | Equity Share |
| 06 Jun, 2025 | 6 | FINAL | 06 Jun, 2025 | Equity Share |
| 05 Feb, 2025 | 6 | INTERIM | 05 Feb, 2025 | Equity Share |
| 05 Nov, 2024 | 6 | INTERIM | 05 Nov, 2024 | Equity Share |
| 20 Aug, 2024 | 6 | INTERIM | 20 Aug, 2024 | Equity Share |
| 10 Jun, 2024 | 6 | FINAL | 10 Jun, 2024 | Equity Share |
| 13 Feb, 2024 | 12 | INTERIM | 13 Feb, 2024 | Equity Share |
Dr. Lal Pathlabs Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹111.09 | ₹1,642 | ₹1,250 | ₹755.65 | ₹1,003.30 | ₹537.30 |
| % Change | 1.34% | 3.54% | 0.96% | -1.11% | -1.95% | 1.33% |
| Revenue TTM (₹ Cr) | ₹3,590.34 | ₹3,193.79 | ₹4,410.15 | ₹3,904.60 | ₹8,140.30 | ₹5,023.67 |
| Net Profit TTM (₹ Cr) | ₹-240.70 | ₹721.55 | ₹556.46 | ₹241.40 | ₹1,419.19 | ₹1,425.29 |
| PE TTM | -135.10 | 38.70 | 59.90 | 125.30 | 73.80 | 29.60 |
| 1 Year Return | 3.26 | 1.08 | 5 | 17.16 | -9.45 | -34.4 |
| ROCE | -5.15 | 29.84 | 15.06 | 8.35 | 12.27 | 43.19 |
FAQ's on LALPATHLAB
What is the current share price of Dr. Lal Pathlabs Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Dr. Lal Pathlabs Ltd. is ₹ 1624.4 on the NSE and ₹ 1624.4 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Dr. Lal Pathlabs Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Dr. Lal Pathlabs Ltd. is approximately ₹ 27972 Cr.
What are the PE and PB ratios for Dr. Lal Pathlabs Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Dr. Lal Pathlabs Ltd. is 55.4, and the Price-to-Book (PB) ratio is 10.9.
What is the 52-Week High and Low for Dr. Lal Pathlabs Ltd.?
Over the past 52 weeks, the highest price reached by Dr. Lal Pathlabs Ltd. shares was ₹ 1770, and the lowest price was ₹ 1272.6.
What is the current dividend yield for Dr. Lal Pathlabs Ltd.?
As of 6 June 2025, the dividend yield for Dr. Lal Pathlabs Ltd. is 0.8%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Dr. Lal Pathlabs Ltd.?
Significant shareholdings in Dr. Lal Pathlabs Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Mutual Funds
- FII
- Public
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Dr. Lal Pathlabs Ltd. in the Diversified Consumer Services sector?
In the Diversified Consumer Services sector, Dr. Lal Pathlabs Ltd. is often compared with other major players such as
KRM Ayurveda, Wakefit Innovations, Flywings Simulator Training, Western Overseas Study Abroad, Helloji Holidays and Clear Secured Services for analysis and benchmarking.
What is the latest dividend information for Dr. Lal Pathlabs Ltd.?
Dr. Lal Pathlabs Ltd. last declared a FINAL dividend of ₹ 4 per share for the financial period ending 2026. The record date was set as 2026-06-25, and the payment was/is scheduled around 2026-06-25. For the most current dividend announcements, refer to official company filings.
What is the shareholding pattern for Dr. Lal Pathlabs Ltd.?
As per the filings for the quarter ending Mar 2026, the approximate shareholding pattern for Dr. Lal Pathlabs Ltd. is:
- Promoters: 53.2%
- Domestic Institutional Investors (DII): 21.4%
- Foreign Institutional Investors (FII): 17.2%
- Others (including Public): 0.3%
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy